ID   NCC-GCTB1-C1
AC   CVCL_A9QC
DR   Wikidata; Q102114580
RX   PubMed=32815117;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 13 hours (PubMed=32815117).
CC   Sequence variation: Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=32815117).
CC   Derived from site: In situ; Bone, right distal radius; UBERON=UBERON_0004407.
ST   Source(s): PubMed=32815117
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 7
//
RX   PubMed=32815117; DOI=10.1007/s13577-020-00415-w;
RA   Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I.,
RA   Kikuta K., Kondo T.;
RT   "Establishment and characterization of NCC-GCTB1-C1: a novel
RT   patient-derived cancer cell line of giant cell tumor of bone.";
RL   Hum. Cell 33:1321-1328(2020).
//